Investors Bet on a Hair Loss Treatment Boom
Bloomberg Television · 5:50
After GLP-1 obesity drugs minted a cash-pay blockbuster, Bloomberg’s Avalon Pernell walks through the next investor bet: a new crop of hair-loss drugs aimed at a U.S. market of roughly 50 million men and 30 million wo...